SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID -- Ignore unavailable to you. Want to Upgrade?


To: Rick Costantino who wrote (1598)10/15/1998 6:51:00 PM
From: Roudy  Read Replies (2) | Respond to of 1762
 
It amazes me that IDEC continues to show strong acceptance of Rituxan, yet here we are able to buy the stock for less than before FDA approval of the product. I believe someday, logic will show up and this company's stock price will reflect the tremendous job they have done. However currently, many patients are feeling the benefits of the fruits of their labor.